Navigation Links
Loosen leash on cancer protein 'watchdog,' researchers say

od news than we initially expected."

Mice with such a predisposition generally developed about 50 intestinal lesions within six months of birth, but mice modified for the study had only developed three or fewer within that time frame. Moreover, there was no sign that the mice had aged any faster than normal.

"We checked for the sort of characteristics that the elderly of many mammal species typically show - thinner skin, lower bone density, spinal hunching and the like," Mendrysa said. "We couldn't find any differences between them and normal mice. And their cancer rates were dramatically lower than expected, which turned out to be the more significant finding of the study."

Mendrysa said the results were an enlightening fundamental discovery about suppressing hereditary intestinal cancers. But she also said the work raised a number of questions that would need to be answered before the research could translate into human therapy.

"These mice were genetically modified at conception to produce higher p53 levels, which is quite a different treatment than just giving normal mice a pill," Mendrysa said. "Also, mice in our study are not subject to the same stresses as, for example, a person working on Wall Street. It remains to be seen whether higher p53, in conjunction with other factors such as stress, could still lead to negative consequences such as aging. We'll have to do a lot more work before this becomes a routine part of medicine's anticancer toolkit.

"Essentially, this study validates Mdm2 as a potentially powerful chemopreventative for some kinds of hereditary cancer, and, if used properly, it might perform well without elevating the risks of aging that other groups have found. The benefits seem to outweigh the risks.

"We'd like to expand the research and look into how Mdm2 and p53 affect other cancer predispositions. If we can find the right length for the leash, someday we may be able to find a way to specify i
'"/>

Source:Purdue University


Page: 1 2 3 4

Related biology news :

1. Loosen up, DNA: Leukemia gene changes genetic packaging
2. How an AIDS-Related Cancer Unleashes Inflammation
3. Viral DNA sequence a possible trigger for breast cancer
4. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
5. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Combination therapy boosts effectiveness of telomere-directed cancer cell death
8. Mitochondrial DNA mutations play significant role in prostate cancer
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. BRCA1 causes ovarian cancer through indirect, biochemical route
11. Researchers identify target for cancer drugs

Post Your Comments:
(Date:11/25/2009)...duced in the stomach, may be used to boost resista...sease, Yale School of Medicine researchers report ...rnal of Neuroscience . , Parkinson,s disease is ... area of the midbrain known as the substantia nigr...Reduced production of dopamine in late-stage Parki...
(Date:11/25/2009)...ighters, police officers and ambulance workers fac...enter complex. They battled to save people from th...tackled fires and evacuated as many people as they...000 people. And making their jobs even harder was ...kers and their relatives jammed mobile networks wi...
(Date:11/25/2009)...25, 2009 Soil is the linchpin of the environment,.... Despite that, many students see soil as "just di...l science educators are challenged with the task o...itical importance of soil in the environment. , ... science teachers at University of Nebraska-Lincol...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Enerkem Named an Emerging Cleantech Leader in Canada 14581 1Enerkem Named an Emerging Cleantech Leader in Canada 14581 2Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 1Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 2Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 3Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 4Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 5Escalon 28R 29 Subsidiary Sonomed Introduces New PacScan 28TM 29 Plus A Scan and Pachymeter 5667 6Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3
...light-emitting molecules have enabled researchers ...w the skin surface using only infrared light. A te...rs based at the University of Pennsylvania and the...terials called porphyrins within the surface of a ... within a living rodent. Their findings, which rep...
...ne alternatives to the use of animals in research ...requires using animals as part of the testing, wha...ee for Responsible Medicine, you invent your own t...ed today that PCRM has developed the world,s first...e insulin levels in individuals with diabetes. The...
...s have identified several genetic changes in the b...searchers better understand how and why people bec...he Journal of Neuroscience, researchers reported s...erns regulated by alcohol in two mouse strains kno... number of behavioral responses to acute alcohol a...
Other Biology News:Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2PCRM develops world's first cruelty-free insulin assay 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 2VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 3
(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswir...developer and provider of vaccines, announced toda...to establish Sinovac (Dalian) Vaccine,Technology C...evelop, produce,and commercialize human-use vaccin...rience in developing and commercializing world-cla...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-FirstC...nnounced today that Barry D. Quart, Pharm.D., pres... the Piper Jaffray 21st Annual Health Care Confere...er Jaffray 21st Annual Health Care Conference,Date....m. Eastern Time,Location: The New York Palace Ho...
(Date:11/24/2009)..., , HOUSTON, Nov. 24 /PRNewswire-First...provider of electrical and communications systems ...sidential markets, announced today that its commer...om Manhattan Torcon JV to install the electrical s...acement facility at the U.S. Army Medical Research...
(Date:11/24/2009)... The New York investment ...td (ASX:NEU) has agreed an AU$6.7 mil convertible ...nvestor. The private placement was arranged by KTA... advisor. , New York (PRW...investment bank KTA Capital, LLC ("KTA Capita...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...ections that keep a fly,s gaze stable during compl...ly to obstacles in its flight path, are revealed i...2008). , Scientists from Imperial College London...ts of nerve cells in a fly,s brain that help it pr... to its muscles. This helps it stay agile and resp...
...RNewswire-FirstCall/ - Lorus Therapeutics Inc.,(Lo...the research and,development of pharmaceutical pro...r, today reported financial results for the three ...fied otherwise, all amounts are in Canadian,dollar...cology studies for Lorus, lead anticancer small ...
...uly 21 Zenobia Therapeutics, Inc.,(Zenobia) annou...eir,facility in La Jolla, California. Zenobia was ...d into their new laboratory and office facilities,...as of high-throughput,structural biology and fragm...cus on limited population diseases that are,tradit...
Other Biology Technology:It takes nerves for flies to keep a level head 2Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 2Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 3Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 4Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 5Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 6Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 7Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 8Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company 2
Bovine Albumin from Bovine Serum, Tetramethylrhodamine conjugated/tagged from Molecular Probes (Invitrogen)
...t Services are uniquely positioned to help you pre...rogens experts employ sophisticated, proprietary t...teins that match your needs: Structure/Function St... (metabolic labelling), Protein-protein interactio...
Bovine Albumin from Bovine Serum, Fluorescein conjugated/tagged from Molecular Probes (Invitrogen)
Mouse Anti-L1 Protein of Human Papilloma Virus Monoclonal Antibody, Unconjugated, Clone CAMVIR-1 from BD Biosciences Pharmingen
Biology Products: